Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) shares dropped 10.7% during trading on Monday . The company traded as low as $0.21 and last traded at $0.22. Approximately 2,151,500 shares changed hands during trading, an increase of 254% from the average daily volume of 608,350 shares. The stock had previously closed at $0.25.
Lexaria Bioscience Stock Down 10.7 %
The company has a debt-to-equity ratio of 0.01, a current ratio of 8.52 and a quick ratio of 8.01. The firm has a 50 day moving average of $0.22.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Recommended Stories
- Five stocks we like better than Lexaria Bioscience
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Top Stocks Investing in 5G Technology
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- 10 Best Airline Stocks to Buy
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.